DUSA Pharmaceuticals

MA 2026 Independent Pharmacies

OIG False Claims

Penalty

$20.8 million

Outcome

OIG enforcement action against DUSA Pharmaceuticals for false claims. Penalty: $20.8 million.

Details

DUSA Pharmaceuticals — OIG Enforcement (2026)

OIG took enforcement action against DUSA Pharmaceuticals in MA in 2026 involving false claims violations in the Independent Pharmacies sector.

Penalty: $20.8 million

Violation types: False Claims
Entity type: Pharmacy
Penalty type: Settlement
Location: MA

Source: DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process

How Crucible Prevents This

Crucible's billing compliance controls enforce documentation-to-claims reconciliation, requiring clinical attestation before claims submission and flagging billing patterns that deviate from documented care delivery.

Source: DUSA Pharmaceuticals To Pay U.S. $20.75 Million To Settle False Claims Act Allegations Relating To Promotion Of Unsupported Drug Administration Process

Don't let this happen to your organization. See how Crucible works.

See How Crucible Works